{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T12:02:57Z","timestamp":1777118577556,"version":"3.51.4"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Canadian Initiative for Outcomes in Rheumatology Care"},{"name":"Fonds de Recherche Sant\u00e9 Qu\u00e9bec"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the effect of an educational tool on preeclampsia knowledge, as well as aspirin (ASA) use and adherence in pregnant SLE women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A two-arm parallel randomized controlled trial was conducted recruiting pregnant SLE women up to 17 weeks\u2019 gestation. Participants were randomly assigned to receive either usual-care alone or usual-care plus the tool (laminated card incorporating infographics on preeclampsia in SLE and ASA for prevention). The primary outcome was difference in preeclampsia knowledge scores at the second-trimester visit.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 73 women included, 38 were randomized to the intervention. In the primary analysis of ongoing pregnancies, increase in the mean preeclampsia knowledge scores was 4.0 points (95% CI: 2.4, 5.6) in the intervention group and 2.0 points (95% CI: 0.3, 3.9) in controls, with a mean difference of 1.8 points higher (95% CI: \u22120.5, 4.2) favouring the intervention. Including end-of-pregnancy scores of women with fetal loss (six in each group), the difference was 4.8 points (95% CI: 3.3, 6.9) in the intervention group and 1.9 points (95% CI: 0.3, 3.6) in controls, with a mean increase of 2.5 points (95% CI: 0.3, 4.8) more for the intervention. Using electronic pharmacy data, there was a trend for higher ASA adherence in the intervention group (81%) vs controls (65%; difference 15%, 95% CI: \u22129, 37%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Women with SLE who received an educational tool had greater improvement in preeclampsia knowledge vs controls. This tool may improve ASA use in SLE pregnancies and help optimize outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov, http:\/\/clinicaltrials.gov, NCT03749044.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf334","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T07:53:45Z","timestamp":1750233225000},"page":"5707-5715","source":"Crossref","is-referenced-by-count":4,"title":["An educational tool to improve PREeclamPsia knowledge and Aspirin adheRence in lupus prEgnancies: the PREPARE trial"],"prefix":"10.1093","volume":"64","author":[{"given":"Joo-Young (Esther)","family":"Lee","sequence":"first","affiliation":[{"name":"Centre for Outcomes Research and Evaluation (CORE), Research Institute of McGill University Health Centre , Montr\u00e9al, QC,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9732-616X","authenticated-orcid":false,"given":"Arielle","family":"Mendel","sequence":"additional","affiliation":[{"name":"Centre for Outcomes Research and Evaluation (CORE), Research Institute of McGill University Health Centre , Montr\u00e9al, QC,","place":["Canada"]},{"name":"Division of Rheumatology, Department of Medicine, McGill University Health Centre , Montreal, QC,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9140-8735","authenticated-orcid":false,"given":"Isabelle","family":"Malham\u00e9","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine, McGill University Health Centre , Montreal, QC,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1055-1335","authenticated-orcid":false,"given":"Megan R W","family":"Barber","sequence":"additional","affiliation":[{"name":"Cumming School of Medicine, University of Calgary , Calgary, AB,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3112-9646","authenticated-orcid":false,"given":"Ann E","family":"Clarke","sequence":"additional","affiliation":[{"name":"Cumming School of Medicine, University of Calgary , Calgary, AB,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul R","family":"Fortin","sequence":"additional","affiliation":[{"name":"Centre ARThrite\u2014CHU de Qu\u00e9bec, - Universit\u00e9 Laval, Quebec , QC,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G","family":"Hanly","sequence":"additional","affiliation":[{"name":"Queen Elizabeth II Health Sciences Centre and Dalhousie University , Halifax, NS,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Legge","sequence":"additional","affiliation":[{"name":"Queen Elizabeth II Health Sciences Centre and Dalhousie University , Halifax, NS,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Peschken","sequence":"additional","affiliation":[{"name":"University of Manitoba , Winnipeg, MB,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl A","family":"Laskin","sequence":"additional","affiliation":[{"name":"University of Toronto , Toronto, ON,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5177-2076","authenticated-orcid":false,"given":"Zahi","family":"Touma","sequence":"additional","affiliation":[{"name":"University of Toronto , Toronto, ON,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murray B","family":"Urowitz","sequence":"additional","affiliation":[{"name":"University of Toronto , Toronto, ON,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9515-2802","authenticated-orcid":false,"given":"Sasha","family":"Bernatsky","sequence":"additional","affiliation":[{"name":"Centre for Outcomes Research and Evaluation (CORE), Research Institute of McGill University Health Centre , Montr\u00e9al, QC,","place":["Canada"]},{"name":"Division of Rheumatology, Department of Medicine, McGill University Health Centre , Montreal, QC,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7727-5879","authenticated-orcid":false,"given":"\u00c9velyne","family":"Vinet","sequence":"additional","affiliation":[{"name":"Centre for Outcomes Research and Evaluation (CORE), Research Institute of McGill University Health Centre , Montr\u00e9al, QC,","place":["Canada"]},{"name":"Division of Rheumatology, Department of Medicine, McGill University Health Centre , Montreal, QC,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"2025110820515576400_keaf334-B1","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: pathophysiology, Challenges, and Perspectives","volume":"124","author":"Rana","year":"2019","journal-title":"Circ Res"},{"key":"2025110820515576400_keaf334-B2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","article-title":"The global impact of pre-eclampsia and eclampsia","volume":"33","author":"Duley","year":"2009","journal-title":"Semin Perinatol."},{"key":"2025110820515576400_keaf334-B3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11906-020-1026-8","article-title":"Novel interventions for the prevention of preeclampsia","volume":"22","author":"Ma'ayeh","year":"2020","journal-title":"Curr Hypertens Rep."},{"key":"2025110820515576400_keaf334-B4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/10641963.2018.1523919","article-title":"Assessment of occurrence of preeclampsia and some clinical and demographic risk factors in Zahedan city in 2017","volume":"41","author":"Farzaneh","year":"2019","journal-title":"Clin Exp Hypertens"},{"key":"2025110820515576400_keaf334-B5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0301-2115(03)00161-1","article-title":"Social deprivation and poor access to care as risk factors for severe pre-eclampsia","volume":"111","author":"Haelterman","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"2025110820515576400_keaf334-B6","first-page":"491","article-title":"Preeclampsia. a nested, case-control study of risk factors and their interactions","volume":"41","author":"Mittendorf","year":"1996","journal-title":"J Reprod Med"},{"key":"2025110820515576400_keaf334-B7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00007611-200405000-00005","article-title":"Is eclampsia preventable? A case control review of consecutive cases from an urban underserved region","volume":"97","author":"Ogunyemi","year":"2004","journal-title":"South Med J"},{"key":"2025110820515576400_keaf334-B8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/10641955.2010.507851","article-title":"Factors associated with patient understanding of preeclampsia","volume":"31","author":"You","year":"2012","journal-title":"Hypertens Pregnancy"},{"key":"2025110820515576400_keaf334-B9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"key":"2025110820515576400_keaf334-B10","first-page":"551","article-title":"Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis","volume":"29","author":"Roberge","year":"2012","journal-title":"Am J Perinatol"},{"key":"2025110820515576400_keaf334-B11","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"key":"2025110820515576400_keaf334-B12","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"EULAR recommendations for women\u2019s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","volume":"76","author":"Andreoli","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2025110820515576400_keaf334-B13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/acr.24130","article-title":"2020 American college of rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Care Res"},{"key":"2025110820515576400_keaf334-B14","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/annrheumdis-2018-214434","article-title":"Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort","volume":"78","author":"Mendel","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2025110820515576400_keaf334-B15","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2025110820515576400_keaf334-B16","doi-asserted-by":"crossref","first-page":"431.e1","DOI":"10.1016\/j.ajog.2012.03.006","article-title":"Improving patient understanding of preeclampsia: a randomized controlled trial","volume":"206","author":"You","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"2025110820515576400_keaf334-B17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/10641955.2017.1397691","article-title":"Preeclampsia knowledge among women in Utah","volume":"37","author":"Wilkinson","year":"2018","journal-title":"Hypertens Pregnancy"},{"key":"2025110820515576400_keaf334-B18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1524-4733.2008.00400.x","article-title":"Development and evaluation of the Adherence to Refills and Medications Scale (ARMS) among low-literacy patients with chronic disease","volume":"12","author":"Kripalani","year":"2009","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"key":"2025110820515576400_keaf334-B19","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1056\/NEJMsr1203730","article-title":"The prevention and treatment of missing data in clinical trials","volume":"367","author":"Little","year":"2012","journal-title":"N Engl J Med"},{"key":"2025110820515576400_keaf334-B20","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1177\/0961203314536480","article-title":"Patient-health care provider relationship: how can it impact on APS (Hughes\u2019 syndrome) adherence to treatment?","volume":"23","author":"Levy","year":"2014","journal-title":"Lupus"},{"key":"2025110820515576400_keaf334-B21","doi-asserted-by":"crossref","first-page":"e1269","DOI":"10.1542\/peds.2011-1702","article-title":"Supplemental written information improves prenatal counseling: a randomized trial","volume":"129","author":"Muthusamy","year":"2012","journal-title":"Pediatrics"},{"key":"2025110820515576400_keaf334-B22","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511996214","volume-title":"Measurement in medicine\u202f: a practical guide","author":"De Vet","year":"2011"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf334\/63530476\/keaf334.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/11\/5707\/63530476\/keaf334.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/11\/5707\/63530476\/keaf334.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T01:52:06Z","timestamp":1762653126000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/11\/5707\/8169700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":22,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,6,20]]},"published-print":{"date-parts":[[2025,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf334","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,6,20]]}}}